CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 651,000	$ 2,178,000
Other current assets	52,000	65,000
Total current assets	703,000	2,243,000
Other assets:
Due from related parties	9,000	930,000
Investments in unconsolidated entities	152,000	141,000
Goodwill	315,000	315,000
Total other assets	476,000	1,386,000
Property and equipment:
Operating lease right-of-use asset	30,000	59,000
Total property and equipment	30,000	59,000
TOTAL ASSETS	1,209,000	3,688,000
Current liabilities:
Operating lease right-of-use liability - current portion	34,000	43,000
Accounts payable and accrued expenses	71,000	169,000
Income taxes payable	231,000	414,000
Total current liabilities	336,000	626,000
Operating lease right-of-use liability - net of current portion	0	23,000
Guarantee liability	11,000	11,000
Total liabilities	347,000	660,000
EQUITY
Common stock - par value $.01; 25,000,000 shares authorized; 7,842,185 and 7,792,185 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively.	78,000	78,000
Additional paid-in capital	2,871,000	2,871,000
Accumulated deficit	(2,214,000)	(373,000)
U.S. Neurosurgical Holdings, Inc. stockholders' equity	735,000	2,576,000
Noncontrolling interests	127,000	452,000
Total equity	862,000	3,028,000
TOTAL LIABILITIES AND EQUITY	$ 1,209,000	$ 3,688,000